Cargando…

SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?

Background Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of insulin-dependent diabetes. Unfortunately, delayed resulting of serum and/or urine studies may hinder timely diagnosis and intervention, thus contributing to negative outcomes. With the recent availability of im...

Descripción completa

Detalles Bibliográficos
Autores principales: Knoll, Michelle, Halpin, Kelsee, McDonough, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552282/
http://dx.doi.org/10.1210/js.2019-SAT-144
_version_ 1783424567359832064
author Knoll, Michelle
Halpin, Kelsee
McDonough, Ryan
author_facet Knoll, Michelle
Halpin, Kelsee
McDonough, Ryan
author_sort Knoll, Michelle
collection PubMed
description Background Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of insulin-dependent diabetes. Unfortunately, delayed resulting of serum and/or urine studies may hinder timely diagnosis and intervention, thus contributing to negative outcomes. With the recent availability of immediate results from capillary BOHB testing, there is the potential for POC BOHB testing to expedite the diagnosis, and therefore, management of DKA in the emergency department (ED). Objective Guidelines released from the International Society of Pediatric and Adolescent Diabetes (ISPAD) in 2018 define a serum BOHB level of >/= 3.0 mmol/L as indicative of DKA. The objective of our investigation was to describe the diagnostic characteristics of POC capillary BOHB testing to predict DKA among pediatric patients presenting to the ED with hyperglycemia. Methods We reviewed pediatric ED encounters from January 2015 through June 2018 for patients with known or newly-diagnosed diabetes mellitus, where the triage POC glucose was > 200 mg/dL and POC BOHB and serum bicarbonate data were available. The outcome variable of interest was DKA, defined as a serum bicarbonate level less than 15 mmol/L per ISPAD criteria. Test characteristics of POC BOHB >/= 3.0 mmol/L, including sensitivity, specificity, positive-predictive value, and negative-predictive value were calculated. A receiver operating characteristics (ROC) curve was developed to describe the accuracy of POC BOHB to predict DKA. Sub-analyses were performed for newly-diagnosed vs. known diabetes patients. Results A total of 463 ED encounters were reviewed, 34% were newly-diagnosed diabetes patients, and 77% of encounters were in DKA based on serum bicarbonate < 15 mmol/L. Only 13 patients (3%) had a POC BOHB < 3.0 mmol/L. The sensitivity, specificity, positive-predictive value, and negative-predictive value of a POC BOHB level =/> 3.0 mmol/L to predict DKA were 98%, 4%, 77%, and 31%, respectively. The ROC curve demonstrated an area under the curve (AUC) of 0.721 (0.670-0.773). The optimal cut off value of POC BOHB was 4.8 mmol/L with a sensitivity of 74% and specificity of 61% for predicting DKA. The AUC for known diabetes patients was 0.742 (0.677-0.807) compared to 0.724 (0.641-0.807) for newly-diagnosed patients. Conclusion Serum BOHB levels indicative of DKA cannot be extrapolated to POC BOHB testing in children with diabetes presenting to the ED. Overall, for both known and newly-diagnosed children with diabetes, POC BOHB testing is poor-to-fair predictor of DKA in the ED setting.
format Online
Article
Text
id pubmed-6552282
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65522822019-06-13 SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department? Knoll, Michelle Halpin, Kelsee McDonough, Ryan J Endocr Soc Diabetes Mellitus and Glucose Metabolism Background Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of insulin-dependent diabetes. Unfortunately, delayed resulting of serum and/or urine studies may hinder timely diagnosis and intervention, thus contributing to negative outcomes. With the recent availability of immediate results from capillary BOHB testing, there is the potential for POC BOHB testing to expedite the diagnosis, and therefore, management of DKA in the emergency department (ED). Objective Guidelines released from the International Society of Pediatric and Adolescent Diabetes (ISPAD) in 2018 define a serum BOHB level of >/= 3.0 mmol/L as indicative of DKA. The objective of our investigation was to describe the diagnostic characteristics of POC capillary BOHB testing to predict DKA among pediatric patients presenting to the ED with hyperglycemia. Methods We reviewed pediatric ED encounters from January 2015 through June 2018 for patients with known or newly-diagnosed diabetes mellitus, where the triage POC glucose was > 200 mg/dL and POC BOHB and serum bicarbonate data were available. The outcome variable of interest was DKA, defined as a serum bicarbonate level less than 15 mmol/L per ISPAD criteria. Test characteristics of POC BOHB >/= 3.0 mmol/L, including sensitivity, specificity, positive-predictive value, and negative-predictive value were calculated. A receiver operating characteristics (ROC) curve was developed to describe the accuracy of POC BOHB to predict DKA. Sub-analyses were performed for newly-diagnosed vs. known diabetes patients. Results A total of 463 ED encounters were reviewed, 34% were newly-diagnosed diabetes patients, and 77% of encounters were in DKA based on serum bicarbonate < 15 mmol/L. Only 13 patients (3%) had a POC BOHB < 3.0 mmol/L. The sensitivity, specificity, positive-predictive value, and negative-predictive value of a POC BOHB level =/> 3.0 mmol/L to predict DKA were 98%, 4%, 77%, and 31%, respectively. The ROC curve demonstrated an area under the curve (AUC) of 0.721 (0.670-0.773). The optimal cut off value of POC BOHB was 4.8 mmol/L with a sensitivity of 74% and specificity of 61% for predicting DKA. The AUC for known diabetes patients was 0.742 (0.677-0.807) compared to 0.724 (0.641-0.807) for newly-diagnosed patients. Conclusion Serum BOHB levels indicative of DKA cannot be extrapolated to POC BOHB testing in children with diabetes presenting to the ED. Overall, for both known and newly-diagnosed children with diabetes, POC BOHB testing is poor-to-fair predictor of DKA in the ED setting. Endocrine Society 2019-04-30 /pmc/articles/PMC6552282/ http://dx.doi.org/10.1210/js.2019-SAT-144 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Diabetes Mellitus and Glucose Metabolism
Knoll, Michelle
Halpin, Kelsee
McDonough, Ryan
SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
title SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
title_full SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
title_fullStr SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
title_full_unstemmed SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
title_short SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
title_sort sat-144 can point-of-care betahydroxybutyrate testing be used to predict diabetic ketoacidosis in the pediatric emergency department?
topic Diabetes Mellitus and Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552282/
http://dx.doi.org/10.1210/js.2019-SAT-144
work_keys_str_mv AT knollmichelle sat144canpointofcarebetahydroxybutyratetestingbeusedtopredictdiabeticketoacidosisinthepediatricemergencydepartment
AT halpinkelsee sat144canpointofcarebetahydroxybutyratetestingbeusedtopredictdiabeticketoacidosisinthepediatricemergencydepartment
AT mcdonoughryan sat144canpointofcarebetahydroxybutyratetestingbeusedtopredictdiabeticketoacidosisinthepediatricemergencydepartment